📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. (2019)

First Author: Mehanna H
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(18)32752-1

PubMed Identifier: 30449623

Publication URI: http://europepmc.org/abstract/MED/30449623

Type: Journal Article/Review

Volume: 393

Parent Publication: Lancet (London, England)

Issue: 10166

ISSN: 0140-6736